top of page

Engaging Conversations: Chats with MPN Specialists

Embark on a journey of enlightening dialogues surrounding Myeloproliferative Neoplasms (MPNs) with the distinguished specialists in the field. These live chats offer a unique opportunity to delve into the intricacies of Polycythemia Vera (PV) and Essential Thrombocythemia (ET) with the expertise of Prof. Haifa Al-Ali and Prof. J. J. Kiladjian, held in the backdrop of the esteemed 3rd MPN Spring Symposium. Prepare to gain invaluable insights and knowledge, enhancing your comprehension of these complex conditions.


PV and ET Insights

Immerse yourself in a live chat featuring Prof. Haifa Al-Ali and Prof. J. J. Kiladjian as they navigate the intricacies of PV and ET, presented during the 3rd MPN Spring Symposium. Some of the topics were about the different types of Interferon, the importance of mental health and symptoms like fatigue in MPN patients. Watch the enlightening discussion here.


Summary

Transcription



Expert Panel Discussion

Tune into an engaging discussion led by a panel of experts, including Prof. Serge Verstovsek, Prof. Haifa Al-Ali, and Doz. Veronika Buxhofer, all part of the prestigious 3rd MPN Spring Symposium. Gain profound perspectives and insights from these distinguished professionals, talking about MPNs, new drugs and young people affected by these diseases. Watch the illuminating discussion here.


Summary

Transcription


Unlock a treasure trove of knowledge and insights through our "Chats with MPN Specialists" series, presented against the backdrop of the 3rd MPN Spring Symposium. Engage in these live conversations featuring leading experts in the realm of Myeloproliferative Neoplasms (MPNs). Prof. Haifa Al-Ali, Prof. J. J. Kiladjian, Prof. Serge Verstovsek, and Doz. Veronika Buxhofer provides unparalleled insights into Polycythemia Vera (PV) and Essential Thrombocythemia (ET).


Stay connected, participate in the discussions, and deepen your understanding of these conditions. Watch and learn from the experts!


190 views0 comments

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
bottom of page